Ginette 2,0 mg/ 0,035 mg FC tablets
PDF Leaflet Revision Date: 10 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Oral contraception and anti-androgen therapy in women.
Dosage (summary)
One tablet daily, starting on the first day of the menstrual cycle.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; may reduce milk production during lactation.
Key Drug Interactions
- Hepatic enzyme inducers
- Anticonvulsants
- Antibiotics
Contraindications
- Pregnancy
- Breast cancer
- Severe hepatic disease
- Thrombo-embolic disorders
Common side effects
- Headache
- Depressed mood
- Breast tenderness
Counselling Points
- Take at the same time daily
- Use additional contraception if missed dose
- Monitor for mood changes
Serious warnings
- Increased risk of thromboembolism
- Not for use in smokers over 35
Important Disclaimer
The Ginette 2,0 mg/ 0,035 mg FC tablets professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
